. Apo:-apoprotein and . Bfm, Body fat mass; BMI: Body mass index; DXA: Dual energy X-ray absorptiometry; FCR: Fractional catabolic rate; FFA: Free fatty acids; FFM: Fat free mass; HDL-c: High-density lipoprotein-cholesterol

F. Marseille, Department of Nutrition, Metabolic diseases, Endocrinology, 13005 Marseille, France. 6 Aix- Nogueira et al, Nutrition & Metabolism, vol.20121, issue.99, p.1717

R. Eckel, S. Grundy, and P. Zimmet, The metabolic syndrome, The Lancet, vol.365, issue.9468, pp.1415-1428, 2005.
DOI : 10.1016/S0140-6736(05)66378-7

G. Whitlock, S. Lewington, P. Sherliker, R. Clarke, J. Emberson et al., Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies, Lancet, vol.373, pp.1083-1096, 2009.

M. Adiels, S. Olofsson, M. Taskinen, and J. Boren, Overproduction of Very Low-Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.7, pp.1225-1236, 2008.
DOI : 10.1161/ATVBAHA.107.160192

P. Barter, A. Gotto, J. Larosa, J. Maroni, M. Szarek et al., HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events, New England Journal of Medicine, vol.357, issue.13, pp.1301-1310, 2007.
DOI : 10.1056/NEJMoa064278

R. Wildman, P. Muntner, K. Reynolds, A. Mcginn, S. Rajpathak et al., The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering, Archives of Internal Medicine, vol.168, issue.15, pp.1617-1624, 1999.
DOI : 10.1001/archinte.168.15.1617

T. Mclaughlin, C. Lamendola, A. Liu, and F. Abbasi, Visceral Depots Is Associated with Insulin Sensitivity, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.11, pp.1756-1760, 2011.
DOI : 10.1210/jc.2011-0615

P. Mathieu, P. Poirier, P. Pibarot, I. Lemieux, and J. Despres, Visceral Obesity: The Link Among Inflammation, Hypertension, and Cardiovascular Disease, Hypertension, vol.53, issue.4, pp.577-584, 2009.
DOI : 10.1161/HYPERTENSIONAHA.108.110320

C. Zou and J. Shao, Role of adipocytokines in obesity-associated insulin resistance, The Journal of Nutritional Biochemistry, vol.19, issue.5, pp.277-286, 2008.
DOI : 10.1016/j.jnutbio.2007.06.006

R. Peterson, L. Beeson, E. Shulz, A. Firek, D. Leon et al., Impacting obesity and glycemic control using a culturally-sensitive diabetes education program in Hispanic patients with type 2 diabetes, Int J Body Compos Res, vol.8, pp.85-94, 2010.

G. Watts and S. Gan, Nutrition and metabolism: non-alcoholic fatty liver disease ??? pathogenesis, cardiovascular risk and therapy, Current Opinion in Lipidology, vol.19, issue.1, pp.92-94, 2008.
DOI : 10.1097/MOL.0b013e3282f41b4f

E. Boes, S. Coassin, B. Kollerits, I. Heid, and F. Kronenberg, Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: A systematic in-depth review, Experimental Gerontology, vol.44, issue.3, pp.136-160, 2009.
DOI : 10.1016/j.exger.2008.11.003

URL : https://hal.archives-ouvertes.fr/hal-00493092

R. Barazzoni, M. Zanetti, C. Ferreira, P. Vinci, A. Pirulli et al., Relationships between Desacylated and Acylated Ghrelin and Insulin Sensitivity in the Metabolic Syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.10, pp.3935-3940, 2007.
DOI : 10.1210/jc.2006-2527

S. Grundy, J. Cleeman, S. Daniels, K. Donato, R. Eckel et al., Diagnosis and management of the metabolic syndrome, Current Opinion in Cardiology, vol.21, issue.1, pp.2735-2752, 2005.
DOI : 10.1097/01.hco.0000200416.65370.a0

H. Duez, B. Lamarche, K. Uffelman, R. Valero, J. Cohn et al., Hyperinsulinemia Is Associated With Increased Production Rate of Intestinal Apolipoprotein B-48-Containing Lipoproteins in Humans, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.6, pp.1357-1363, 2006.
DOI : 10.1161/01.ATV.0000222015.76038.14

S. Rashid, T. Watanabe, T. Sakaue, and G. Lewis, Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity, Clinical Biochemistry, vol.36, issue.6, pp.421-429, 2003.
DOI : 10.1016/S0009-9120(03)00078-X

J. Lopez-miranda, C. Williams, and D. Lairon, Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism, British Journal of Nutrition, vol.46, issue.03, pp.458-473, 2007.
DOI : 10.1016/S0895-7061(01)02141-0

S. Beliard, J. Nogueira, M. Maraninchi, D. Lairon, A. Nicolay et al., Parallel increase of plasma apoproteins C-II and C-III in Type 2 diabetic patients, Diabetic Medicine, vol.168, issue.7, pp.736-739, 2009.
DOI : 10.1111/j.1464-5491.2009.02757.x

T. Ng, G. Watts, M. Farvid, D. Chan, and P. Barrett, Adipocytokines and VLDL Metabolism: Independent Regulatory Effects of Adiponectin, Insulin Resistance, and Fat Compartments on VLDL Apolipoprotein B-100 Kinetics?, Diabetes, vol.54, issue.3, pp.795-802, 2005.
DOI : 10.2337/diabetes.54.3.795

L. Martin, J. Woo, S. Daniels, E. Goodman, and L. Dolan, The Relationships of Adiponectin with Insulin and Lipids Are Strengthened with Increasing Adiposity, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.7, pp.4255-4259, 2005.
DOI : 10.1210/jc.2005-0019

M. Schulze, E. Rimm, I. Shai, N. Rifai, and F. Hu, Relationship Between Adiponectin and Glycemic Control, Blood Lipids, and Inflammatory Markers in Men With Type 2 Diabetes, Diabetes Care, vol.27, issue.7, pp.1680-1687, 2004.
DOI : 10.2337/diacare.27.7.1680

D. Chan, P. Barrett, E. Ooi, J. J. Chan, D. Watts et al., Very Low Density Lipoprotein Metabolism and Plasma Adiponectin as Predictors of High-Density Lipoprotein Apolipoprotein A-I Kinetics in Obese and Nonobese Men, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.3, pp.989-997, 2009.
DOI : 10.1210/jc.2008-1457

B. Verges, J. Petit, L. Duvillard, G. Dautin, E. Florentin et al., Adiponectin Is an Important Determinant of ApoA-I Catabolism, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.6, pp.1364-1369, 2006.
DOI : 10.1161/01.ATV.0000219611.50066.bd

J. Schneider, M. Von-eynatten, S. Schiekofer, P. Nawroth, and K. Dugi, Low Plasma Adiponectin Levels Are Associated With Increased Hepatic Lipase Activity In Vivo, Diabetes Care, vol.28, issue.9, pp.2181-2186, 2005.
DOI : 10.2337/diacare.28.9.2181

M. Miller, N. Stone, C. Ballantyne, V. Bittner, M. Criqui et al., Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association, Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association, pp.2292-2333, 2011.
DOI : 10.1161/CIR.0b013e3182160726

C. Tan and A. Vidal-puig, Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese, Biochemical Society Transactions, vol.36, issue.5, pp.935-940, 2008.
DOI : 10.1042/BST0360935

F. Magkos, E. Fabbrini, J. Mccrea, B. Patterson, J. Eagon et al., Decrease in hepatic very-low-density lipoprotein-triglyceride secretion after weight loss is inversely associated with changes in circulating leptin, Diabetes, Obesity and Metabolism, vol.65, issue.(Suppl 42), pp.584-590, 2010.
DOI : 10.1111/j.1463-1326.2009.01191.x

A. Kontush and M. Chapman, Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis, Pharmacological Reviews, vol.58, issue.3, pp.342-374, 2006.
DOI : 10.1124/pr.58.3.1

S. Poykko, E. Kellokoski, S. Horkko, H. Kauma, Y. Kesaniemi et al., Low Plasma Ghrelin Is Associated With Insulin Resistance, Hypertension, and the Prevalence of Type 2 Diabetes, Diabetes, vol.52, issue.10, pp.2546-2553, 2003.
DOI : 10.2337/diabetes.52.10.2546

N. Beaumont, V. Skinner, T. Tan, B. Ramesh, D. Byrne et al., Ghrelin Can Bind to a Species of High Density Lipoprotein Associated with Paraoxonase, Journal of Biological Chemistry, vol.278, issue.11, pp.8877-8880, 2003.
DOI : 10.1074/jbc.C200575200

N. Le and H. Ginsberg, Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol, Metabolism, vol.37, issue.7, pp.614-617, 1988.
DOI : 10.1016/0026-0495(88)90077-7

E. Brinton, S. Eisenberg, and J. Breslow, Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia., Journal of Clinical Investigation, vol.87, issue.2, pp.536-544, 1991.
DOI : 10.1172/JCI115028

H. Gylling, G. Vega, and S. Grundy, Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids, J Lipid Res, vol.33, pp.1527-1539, 1992.

J. Ji, G. Watts, A. Johnson, D. Chan, E. Ooi et al., High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.3, pp.973-979, 2006.
DOI : 10.1210/jc.2005-1895

H. Choi, Y. Cho, M. Moon, H. Choi, H. Shin et al., Polymorphisms in the ghrelin gene are associated with serum Nogueira et al, Nutrition & Metabolism, vol.20121, issue.99, pp.17-17